Adma Biologics (ADMA) Assets (2011 - 2026)
Adma Biologics (ADMA) recorded Assets of $684.21 million in Q2 2026, up 22.5% from $558.38 million a year earlier and up 2.9% from the prior quarter.
Powered by 
Analysis
Adma Biologics (ADMA) Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Adma Biologics reported Assets of $624.24 million, up 27.7% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
- Across earlier years, Assets came in at $488.68 million in FY2024 (+48.5%), $329.18 million in FY2023 (-5.5%), $348.46 million in FY2022 (+26.1%) and $276.25 million in FY2021 (+33.0%).
- The Q2 2026 figure is the highest quarterly Assets in data going back to Q2 2011.
- On a year-over-year basis, Assets has increased for ten consecutive quarters, with growth averaging 35.0% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 48.5% in Q4 2024, against a decline of 5.5% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $665.18 million (Q1 2026), $624.24 million (Q4 2025) and $568.69 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Adma Biologics | 2.28 Bn | 1.86 Bn | 86.28 Mn | 684.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 684.21 Mn |
| Mar 31, 2026 | 665.18 Mn |
| Dec 31, 2025 | 624.24 Mn |
| Sep 30, 2025 | 568.69 Mn |
| Jun 30, 2025 | 558.38 Mn |
| Mar 31, 2025 | 510.57 Mn |
| Dec 31, 2024 | 488.68 Mn |
| Sep 30, 2024 | 390.62 Mn |
| Jun 30, 2024 | 376.40 Mn |
| Mar 31, 2024 | 350.88 Mn |
| Dec 31, 2023 | 329.18 Mn |
| Sep 30, 2023 | 349.00 Mn |
| Jun 30, 2023 | 343.03 Mn |
| Mar 31, 2023 | 340.79 Mn |
| Dec 31, 2022 | 348.46 Mn |
| Sep 30, 2022 | 300.56 Mn |
| Jun 30, 2022 | 296.93 Mn |
| Mar 31, 2022 | 308.03 Mn |
| Dec 31, 2021 | 276.25 Mn |
| Sep 30, 2021 | 238.64 Mn |
API Access
Adma Biologics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ADMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ADMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ADMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();